These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24689036)

  • 1. A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.
    Taurin S; Nehoff H; van Aswegen T; Rosengren RJ; Greish K
    Biomed Res Int; 2014; 2014():323594. PubMed ID: 24689036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer.
    Pritchard T; Rosengren RJ; Greish K; Taurin S
    J Drug Target; 2016; 24(5):441-9. PubMed ID: 26373825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.
    Archibald M; Pritchard T; Nehoff H; Rosengren RJ; Greish K; Taurin S
    Int J Nanomedicine; 2016; 11():179-200. PubMed ID: 26811677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
    Enteshari S; Varshosaz J; Minayian M; Hassanzadeh F
    Invest New Drugs; 2018 Apr; 36(2):206-216. PubMed ID: 29177974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
    Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor.
    Greish K; Nehoff H; Bahman F; Pritchard T; Taurin S
    J Drug Target; 2019 Sep; 27(8):903-916. PubMed ID: 30615483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer.
    Xian S; Parayath NN; Nehoff H; Giles NM; Greish K
    Anticancer Res; 2015 Sep; 35(9):4707-12. PubMed ID: 26254360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
    Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
    J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.
    Yang R; Ma YX; Chen LF; Zhou Y; Yang ZP; Zhu Y; Du XL; Shi JD; Ma HS; Zhang J
    Asian J Androl; 2010 Sep; 12(5):735-43. PubMed ID: 20473319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue Distribution and Systemic Toxicity Evaluation of Raloxifene Targeted Polymeric Micelles of Poly (Styrene-Maleic Acid)-Poly (Amide- Ether-Ester-Imide)-Poly (Ethylene Glycol) Loaded With Docetaxel in Breast Cancer Bearing Mice.
    Varshosaz J; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Enteshari S
    Recent Pat Anticancer Drug Discov; 2019 Nov; 14(3):280-291. PubMed ID: 31538904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease.
    Greish K; Taha S; Jasim A; Elghany SA; Sultan A; AlKhateeb A; Othman M; Jun F; Taurin S; Bakhiet M
    Clin Transl Med; 2017 Dec; 6(1):28. PubMed ID: 28770521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.
    Ho TH; Nunez-Nateras R; Hou YX; Bryce AH; Northfelt DW; Dueck AC; Wong B; Stanton ML; Joseph RW; Castle EP
    Clin Genitourin Cancer; 2017 Apr; 15(2):196-202.e1. PubMed ID: 27771244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases.
    Daruwalla J; Nikfarjam M; Greish K; Malcontenti-Wilson C; Muralidharan V; Christophi C; Maeda H
    Cancer Sci; 2010 Aug; 101(8):1866-74. PubMed ID: 20579075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance.
    Balaburski GM; Dardes RC; Johnson M; Haddad B; Zhu F; Ross EA; Sengupta S; Klein-Szanto A; Liu H; Lee ES; Kim H; Jordan VC
    Int J Oncol; 2010 Aug; 37(2):387-98. PubMed ID: 20596666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.
    Larson N; Greish K; Bauer H; Maeda H; Ghandehari H
    Int J Pharm; 2011 Nov; 420(1):111-7. PubMed ID: 21856392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer.
    Abudurexiti M; Zhu W; Wang Y; Wang J; Xu W; Huang Y; Zhu Y; Shi G; Zhang H; Zhu Y; Shen Y; Dai B; Wan F; Lin G; Ye D
    Prostate; 2020 Sep; 80(12):950-961. PubMed ID: 32648618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models.
    Toren P; Kim S; Cordonnier T; Crafter C; Davies BR; Fazli L; Gleave ME; Zoubeidi A
    Eur Urol; 2015 Jun; 67(6):986-990. PubMed ID: 25151012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase-induced endogenous estrogen promotes tumour metastasis through estrogen receptor-α/matrix metalloproteinase 12 axis activation in castration-resistant prostate cancer.
    Liang Z; Cao J; Tian L; Shen Y; Yang X; Lin Q; Zhang R; Liu H; Du X; Shi J; Zhang J
    Cancer Lett; 2019 Dec; 467():72-84. PubMed ID: 31499120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.